Arecor Therapeutics announced today that it signed a co-development with Sequel Med Tech to pair their diabetes offerings. Cambridge, UK-based Arecor develops AT278 (500U/mL) ultra-rapid-acting insulin. The companies struck a deal to pair the insulin with the Sequel twiist automated insulin delivery system. Additionally, the deal includes a financing agreement with Ligand Pharmaceuticals to bring […]
Sequel Med Tech
Sequel Med Tech expects full twiist launch this year
Sequel Med Tech has offered insight into the next steps of the launch of its twiist automated insulin delivery (AID) system. The company shared at last month’s American Diabetes Association’s 85th Scientific Sessions in Chicago that it planned to begin the launch of the highly anticipated twiist system. The initial launch comes with the Abbott […]
The biggest diabetes tech stories out of ADA 2025
The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association’s 85th Scientific Sessions. At last year’s edition in Orlando, type 2 diabetes dominated the conversation. This time around, type 2 remained a hot topic, alongside new players in the continuous glucose monitor (CGM) and automated insulin delivery market, […]
Breaking: Sequel to launch twiist automated insulin delivery system next month
Sequel Med Tech announced at the American Diabetes Association’s 85th Scientific Sessions in Chicago that it plans to launch its twiist system in July. Dr. Joanna Mitri, the company’s chief medical officer, shared the update in a Product Theater session at the ADA Scientific Sessions in Chicago today. Mitri said the company plans to launch […]
Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor
Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott sensor. The companies agreed to pair twiist, powered by Tidepool, with Abbott‘s glucose-ketone sensor, currently under development. Sequel said the agreement aims to improve outcomes for people with type 1 diabetes. It adds ketone sensing capabilities […]
Sequel Med Tech, Senseonics to integrate year-long CGM into automated insulin delivery system
Sequel Med Tech and Senseonics (NYSE:SENS) today announced a commercial development agreement to combine insulin delivery and glucose monitoring systems. The companies plan to integrate Sequel’s twiist automated insulin delivery system with the Senseonics Eversense 365 continuous glucose monitor (CGM). This collaboration would make twiist the first AID system compatible with Eversense 365, the world’s […]
Doctors issue call to action to eliminate barriers to automated insulin delivery
Key opinion leaders issued a call to action to the diabetes community to recognize the importance of automated insulin delivery (AID). A number of doctors issued this call, published by Mary Ann Liebert’s Diabetes Technology & Therapeutics, to implement the advances made in the AID technology space. They say pivotal trials and real-world data support […]
The biggest diabetes tech news out of ATTD 2025
Last week, Amsterdam played host to this year’s edition of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). For the 18th edition of this event, some of the biggest names in diabetes technology put their latest innovations on display. Updates for insulin delivery and glucose monitoring technologies dominated the headlines as many […]
Sequel Med Tech makes first CGM integration with Abbott for automated insulin pump
Sequel Med Tech announced today that it integrated its twiist automated insulin delivery (AID) with the Abbott FreeStyle Libre 3 Plus sensor. This marks the first continuous glucose monitor (CGM) integration for twiist. Manchester, New Hampshire-based Sequel expects to launch the combination in the second quarter of 2025. Sequel won FDA clearance for the twiist […]
The biggest diabetes tech stories of the year so far
On World Diabetes Day, it’s worth taking a look back at the last 10.5 months in the diabetes technology space. The date, which marks the birth date of the inventor of insulin, brings out all sorts of initiatives from various companies involved in innovating these technologies (read about those HERE). Those companies have contributed to […]
